- Article
Effects of Germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on Mitotane Treatment in Adrenocortical Carcinoma: A Multicenter ENSAT Study
- Barbara Altieri,
- Silviu Sbiera,
- Sabine Herterich,
- Silvia De Francia,
- Silvia Della Casa,
- Anna Calabrese,
- Alfredo Pontecorvi,
- Marcus Quinkler,
- Tina Kienitz and
- Massimo Mannelli
- + 7 authors
Mitotane is the only approved drug for advanced adrenocortical carcinoma (ACC) and no biomarkers are available to predict attainment of therapeutic plasma concentrations and clinical response. Aim of the study was to evaluate the suitability of cytoc...